RxDoctor Payments Data

Cesar Freytes

Hematology & Oncology · San Antonio, TXNPI 1255430435

Payments from drug & device makers

$842,593in general payments, 2019–2025

Across 81 payments — averaging $10,402 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$611K
  • CSL Behring$184K
  • Celularity Inc.$20K
  • Incyte Corporation$18K
  • Sanofi$9K
  • Merck$955
  • plus $255 from 3 others

What the payments were for

  • Speaking & faculty fees$7,67584%
  • Travel & lodging$1,20513%
  • Food & beverage$2643%
  • Education$320%

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$842,593 in reported general payments places this provider in the 85th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas

Other hematology & oncology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →